Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?
- 20 March 2013
- journal article
- research article
- Published by Wiley in Hematological Oncology
- Vol. 32 (1), 1-9
- https://doi.org/10.1002/hon.2046
Abstract
No abstract availableThis publication has 68 references indexed in Scilit:
- Acute myeloid leukaemia in adultsThe Lancet, 2013
- Prognostic Significance of the European LeukemiaNet Standardized System for Reporting Cytogenetic and Molecular Alterations in Adults With Acute Myeloid LeukemiaJournal of Clinical Oncology, 2012
- Acute myeloid leukaemia in the elderly: a reviewBritish Journal of Haematology, 2011
- Molecular Genetics of Adult Acute Myeloid Leukemia: Prognostic and Therapeutic ImplicationsJournal of Clinical Oncology, 2011
- Genetic Abnormalities and Challenges in the Treatment of Acute Myeloid LeukemiaGenes & Cancer, 2011
- Has there been progress in the treatment of older patients with acute myeloid leukemia?Best Practice & Research Clinical Haematology, 2010
- New Prognostic Markers in Acute Myeloid Leukemia: Perspective from the ClinicHematology, 2010
- Treatment of older patients with acute myeloid leukaemiaThe Lancet, 2010
- Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trialsBlood, 2010
- Clinically useful prognostic factors in acute myeloid leukemiaCritical Reviews in Oncology/Hematology, 2008